Synchrony Financial (SYF) Research & Development (2013 - 2026)

Synchrony Financial (SYF) has 14 years of Research & Development data on file, last reported at $248.0 million in Q2 2026.

• Quarterly Research & Development rose 15.35% year-over-year to $248.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $975.0 million (up 15.52% YoY) and the FY2025 annual result came in at $899.0 million, up 11.96% from the prior year.
• Research & Development eased to $248.0 million in Q2 2026, from $262.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $262.0 million in Q1 2026 to a low of $145.0 million in Q1 2022.
• A 5-year average of $197.1 million and a median of $196.5 million in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2025 — Research & Development gained 3.86% — and 2026, when it climbed 19.63%.
• Tracing SYF's Research & Development over 5 years: stood at $165.0 million in 2022, then gained by 15.15% to $190.0 million in 2023, then climbed by 8.95% to $207.0 million in 2024, then grew by 15.46% to $239.0 million in 2025, then increased by 3.77% to $248.0 million in 2026.
• The last three Research & Development figures came in at $248.0 million (Q2 2026), $262.0 million (Q1 2026), and $239.0 million (Q4 2025), per Business Quant data.